Drug Profile
Research programme: therapeutic agents - HUYA Biosciences International
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Chinese Academy of Sciences; Medical Center of Fudan University; Shanghai Pharma Engine; Shanghai Zhangjiang Biotechnology; Shenyang Pharmaceutical University; Shenzhen Polytechnic School of Applied Chemistry and Biotechnolog; Sun Yat-Sen University; Tianjin Institute of Pharmaceutical Research; Tianjin International Joint Academy of Biotechnology and Medicine; Zhangjiang Bio-Pharmaceutical Base Development
- Developer Chinese Academy of Sciences; HUYA Bioscience International; Medical Center of Fudan University; Shenyang Pharmaceutical University; Shenzhen Polytechnic School of Applied Chemistry and Biotechnolog; Sun Yat-Sen University; Tianjin Institute of Pharmaceutical Research; Tianjin International Joint Academy of Biotechnology and Medicine
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Undefined in China
- 20 Oct 2011 Preclinical development is ongoing in China
- 08 Jun 2009 Preclinical trials in Undefined indication in China (unspecified route)